百合股份 (603102)
Weihai Baihe Biology Technological Co., Ltd.
K-Line Chart
No K-line data available
Company NameWeihai Lily Biotechnology Co., Ltd.
Listing Date2022-01-25
Issue Price42.14RMB
Registered Capital640010k RMB
Legal RepresentativeLiu Xinli
Registered AddressNo. 552 Chengda Road, Swan Lake Economic and Technological Development Zone, Rongcheng City, Shandong Province
IndustryFood Processing
Main BusinessResearch, development, production, and sales of nutritional and health foods
Company ProfileWeihai Lily Biotechnology Co., Ltd. is a national high-tech enterprise specializing in the research, development, production, and sales of nutritional and health foods. After years of R&D and accumulation, the company has established large-scale production capabilities for various dosage forms, including soft capsules, hard capsules, tablets, powders, oral liquids, drops, bottled beverages, and bagged beverages. It has also built efficient R&D management and supply chain management systems, providing comprehensive services to domestic and international clients covering product positioning, formula research, production approval, and finished product manufacturing.
The company also adheres to a self-owned brand strategy. While offering contract manufacturing services to domestic and international nutritional and health food brand operators, it actively develops its own brands. The company currently owns self-owned brands such as 'Lily Kang,' 'Fu Zai,' 'Hong Yang Shen,' and 'Zu Li Xing,' targeting different consumer groups including families, infants and young children, high-end individuals, and middle-aged and elderly people. Among them, the 'Lily Kang' brand is a China Famous Trademark recognized by the State Administration for Industry and Commerce. In the future, the company will strengthen the development of product series such as infant complementary foods, sports nutrition foods, and foods for special medical purposes, forming a comprehensive product portfolio that meets the needs of different consumers.
Stock Details
1. Key Indicators
- Total Shares(W): 6400.00
- Circulating A-Shares(W): 6400.00
- Earnings Per Share(RMB): 1.5800
- Net Assets Per Share(RMB): 25.4311
- Operating Revenue(W RMB): 64534.97
- Total Profit(W RMB): 11339.97
- **Net Profit Attributable to Parent(W RMB) **: 9898.97
- Net Profit Growth Rate(%): -15.15
- Weighted Return on Equity(%): 6.0000
- Operating Cash Flow Per Share(RMB): 2.2420
- Undistributed Profit Per Share(RMB): 13.4798
- Capital Reserve Per Share(RMB): 10.2336
2. Main Business
The main business covers:
- Research and development, production, and sales of nutritional and health foods.
3. Company Basic Information
- Company Name: Weihai Baihe Biotechnology Co., Ltd.
- Listing Date: 2022-01-25
- Industry: Food Manufacturing
- Address: No. 552 Chengda Road, Swan Lake Economic and Technological Development Zone, Rongcheng City, Weihai City, Shandong Province
- Website: https://www.baiheshengwu.com
- Company Profile: The company was established through the overall transformation of Rongcheng Baihe into a joint stock company. On July 16, 2013, the company's shareholders' meeting resolved to transform Rongcheng Baihe into a joint stock company. The audited net assets as of March 31, 2013 were RMB 91,422,830.59, converted into 45 million shares, with the remainder recorded as capital reserve. The industrial and commercial change registration was completed on November 14, 2013, with a registered capital of 45 million yuan.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Rongcheng Yongli Investment Management Co., Ltd. | General Legal Person | 57.29 | 0.90 |
| 2 | Noah Active Allocation Mixed Securities Investment Fund Class A | Fund | 12.23 | 0.19 |
5. Concept Sectors
- Vitamins
- NMN Concept
- Pet Economy
- Micro-cap Stocks
- High-performing Stocks
Remarks
- Data update date: 2025-10-30
- Data source: Public market information